Lopid

In the US, Lopid (gemfibrozil systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

• Lopid

UK matches:

• Lopid 300mg Capsules & 600mg Film-coated Tablets (SPC)

Ingredient matches for Lopid

Gemfibrozil

Gemfibrozil is reported as an ingredient of Lopid in the following countries:

• Argentina


• Australia


• Bahrain


• Belize


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• Cyprus


• Denmark


• Ecuador


• Egypt


• El Salvador


• Finland


• Greece


• Guatemala


• Honduras


• Hong Kong


• Iceland


• India


• Indonesia


• Ireland


• Italy


• Jordan


• Kuwait


• Lebanon


• Luxembourg


• Mexico


• Myanmar


• Netherlands


• Nicaragua


• Oman


• Panama


• Peru


• Philippines


• Portugal


• Saudi Arabia


• Singapore


• South Africa


• Spain


• Sweden


• Taiwan


• Thailand


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.